Genome-wide DNA methylation study suggests epigenetic accessibility and transcriptional poising of interferon-regulated genes in naïve CD4+ T cells from lupus patients
Introduction
Systemic lupus erythematosus is a chronic autoimmune disease characterized by the production of antinuclear antibody and multiple organ involvement. The etiology of lupus is incompletely understood, but clear evidence suggests an important role for abnormal T cell DNA methylation in the pathogenesis of the disease [1]. Indeed, demethylated T cells are sufficient to cause a lupus-like disease in mouse models [2].
DNA methylation is an epigenetic mechanism that regulates gene expression by altering transcriptional accessibility of regulatory regions within gene sequences. This chemical modification of cytosine residues most commonly occurs in CG dinucleotides, and is mediated by DNA methyltransferase enzymes [3]. In general, methylation of CG dinucleotides in regulatory sequences induces gene silencing, while hypomethylation allows for transcriptional chromatin accessibility, and active gene expression when appropriate transcription factors are available [3]. DNA methylation induces chromatin inaccessibility by several mechanisms, including recruitment of histone deacetylases that remove acetyl groups from histone tails thereby increasing the charge attraction between DNA and histone proteins to generate more compact chromatin configuration that prevents access by the transcriptional machinery [4].
DNA methylation plays an important role in T cell differentiation. Indeed, the interferon gamma locus demethylates upon TH1 differentiation, and the interleukin (IL)-4, IL-5, and IL-13 common locus control region demethylates upon TH2 differentiation, allowing for interferon gamma, and IL-4, IL-5, and IL-13 production in differentiated TH1 and TH2 cells, respectively [5]. In contrast, both loci are heavily methylated in naïve CD4+ T cells [5].
We have previously characterized DNA methylation changes in total CD4+ T cells from lupus patients and revealed wide-spread DNA methylation changes in patients compared to healthy controls [6]. Herein, we performed an extensive genome-wide DNA methylation study in naïve CD4+ T cells from lupus patients and controls, coupled with gene expression profiling from the same cells. We identified DNA methylation changes prior to T cell differentiation and activation in lupus and determined the effect of these methylation changes on gene expression.
Section snippets
Lupus patients and controls
We studied two independent sets of female lupus patients and controls, each consisting of 36 participants (18 lupus patients and 18 healthy controls). We designed our study to include a discovery cohort and a second independent cohort for replication. The discovery cohort was recruited from the Oklahoma Lupus Cohort at the Oklahoma Medical Research Foundation (OMRF), and the replication cohort was subsequently recruited from the University of Michigan rheumatology clinics. Patients and controls
Results
We identified and then validated DNA methylation changes in naïve CD4+ T cells in lupus using two independent sets of lupus patients and age-, sex-, and ethnicity-matched controls (Table 1). We identified and replicated 86 CG sites that are differentially methylated in naïve CD4+ T cells from lupus patients. Sixty sites were hypomethylated and 26 were hypermethylated in patients compared to controls (Supplementary Table I). A total of 47 differentially methylated unique genes were identified in
Discussion
We performed a genome-wide DNA methylation study coupled with a gene expression profiling experiment in naïve CD4+ T cells from lupus patients and controls. DNA methylation levels were quantified in over 485,000 methylation sites in naïve CD4+ T cells across the entire genome in two independent sets of lupus patients and age-, sex-, and ethnicity-matched controls. Differentially methylated CG sites in lupus were discovered and then replicated, and the effect of the methylation changes detected
Conclusions
We identified and replicated DNA methylation changes in naïve CD4+ T cells from lupus patients for the first time. These data indicate that abnormal DNA methylation exists in lupus T cells even before activation and differentiation. Therefore, our findings emphasize the role of DNA methylation defect in the pathogenesis of the disease. Notably, we propose a model whereby interferon-regulated genes are epigenetically poised to respond to type-I interferon upon T cell activation and provide
Financial conflict of interest
None of the authors has any financial conflict of interest to report.
Acknowledgments
This work was made possible by support from the Lupus Research Institute and the NIH grant number R01AI097134 from the National Institute of Allergy and Infectious Diseases.
References (17)
- et al.
Functional characterization of the MECP2/IRAK1 lupus risk haplotype in human T cells and a human MECP2 transgenic mouse
J Autoimmun
(2013) - et al.
Impaired DNA methylation and its mechanisms in CD4(+)T cells of systemic lupus erythematosus
J Autoimmun
(2013) - et al.
Murine models of lupus induced by hypomethylated T cells (DNA hypomethylation and lupus…)
Methods Mol Biol
(2012) - et al.
Epigenetics in systemic lupus erythematosus: leading the way for specific therapeutic agents
Int J Clin Rheumtol
(2011) - et al.
Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription
Nat Genet
(1998) Epigenetics and T-cell immunity
Autoimmunity
(2008)- et al.
Genome-wide DNA methylation patterns in CD4+ T cells from patients with systemic lupus erythematosus
Epigenetics
(2011) - et al.
Variants within MECP2, a key transcription regulator, are associated with increased susceptibility to lupus and differential gene expression in patients with systemic lupus erythematosus
Arthritis Rheum
(2009)